ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
PCI Pharma Services
The HR Advisor will provide high-quality HR support and guidance across the organisation, partnering with managers and employees on employment law, policies, and best practice. The role includes managing employee relations, recruitment, onboarding, payroll support, HR systems, and contributing to HR projects and continuous improvement initiatives.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
1001-5000 employees
PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success.
Business WirePCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
Jul 14, 2025
Pharmaceutical TechnologyPCI Pharma Services completes acquisition of Ajinomoto Althea
Aug 28, 2025
Contract PharmaPCI Pharma Services Receives Strategic Investment from Bain Capital, Kohlberg and Mubadala
Sep 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PCI Pharma Services.
PCI Pharma Services didn’t post a salary, so this is our estimate from similar listings.
25% below the average for this role
PHILADELPHIA.TodayNortheast Philadelphia’s PCI Pharma Services Receives Massive Investment, Now Valued At $10B
Jul 23, 2025
